• Myeloperoxidase Antibody, IgG
  • Bone Alkaline Phosphatase, Serum
  • 15q Deletion, Type I and Type II Characterization, Prader-Willi/Angelman Syndromes, FISH
  • Alveolar Rhabdomyosarcoma (ARMS) by Reverse Transcriptase PCR (RT-PCR)
  • Prostate Specific Antigen (PSA), Total
  • MDM2 Gene Amplification, FISH
  • Immunoreactive Insulin
  • Manganese, 24 Hour, Urine
  • Protein S, Functional
  • Succinate Dehydrogenase (SDHA, SDHB, SDHC and SDHD) Gene Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Diseases (2)
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.